Peter R. Galle

Also affiliated with University Medical Center of the Johannes Gutenberg University Mainz

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma”.

Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma

New England Journal of Medicine(2020)10.1056/nejmoa1915745

N/A

1.3DataRank · unranked

7029 citations

Shukui Qin, Masafumi Ikeda, Peter R. Galle, Michel Ducreux, Tae-You Kim +19 more

Trial Design and Endpoints in Hepatocellular Carcinoma: AASLD Consensus Conference

Hepatology(2020)10.1002/hep.31327

N/A

0DataRank · unranked

414 citations

Augusto Villanueva, Jorge A. Marrero, Myron E. Schwartz, Tim Meyer, Peter R. Galle +9 more

Reducing mortality and morbidity in patients with severe COVID-19 disease by advancing ongoing trials of Mesenchymal Stromal (stem) Cell (MSC) therapy — Achieving global consensus and visibility for cellular host-directed therapies

International Journal of Infectious Diseases(2020)10.1016/j.ijid.2020.05.040

N/A

0DataRank · unranked

49 citations

Fu‐Sheng Wang, Giuseppe Ippolito, Nicola Petrosillo, Chiara Agrati, Esam I. Azhar +12 more

BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update

Journal of Hepatology(2021)10.1016/j.jhep.2021.11.018

N/A

0DataRank · unranked

4206 citations

Alejandro Forner, Jordi Rimola, Joana Ferrer, Marta Burrel, Ángeles García‐Criado +11 more

Reproducible safety and efficacy of atezolizumab plus bevacizumab for HCC in clinical practice: Results of the AB-real study

European Journal of Cancer(2022)10.1016/j.ejca.2022.08.024

N/A

0DataRank · unranked

112 citations

Jaekyung Cheon, Antonio D’Alessio, Naoshi Nishida, Celina Ang, Thomas U. Marron +32 more

Single-cell RNA sequencing-derived signatures define response patterns to atezolizumab + bevacizumab in advanced hepatocellular carcinoma

Journal of Hepatology(2024)10.1016/j.jhep.2024.12.016

N/A

0DataRank · unranked

44 citations

Marta Piqué‐Gili, Roger Esteban-Fabró, Gino Philips, Ugne Balaseviciute, Roser Pinyol +36 more

PARP-1 selectively impairs KRAS -driven phenotypic and molecular features in intrahepatic cholangiocarcinoma

Gut(2024)10.1136/gutjnl-2023-331237

N/A

0DataRank · unranked

10 citations

Darko Castven, Diana Becker, Stojan R. Stojković, Jovana Castven, Carolin Zimpel +22 more

Evidence and choice: The BCLC vision for tailoring clinical decision-making

Journal of Hepatology(2024)10.1016/j.jhep.2024.04.023

N/A

0DataRank · unranked

3 citations

Alejandro Forner, Jordi Rimola, Joana Ferrer, Marta Burrel, Ángeles García‐Criado +11 more